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Abstract
Background: An artificial neural network approach was chosen to model the
outcome of the complex signaling pathways in the gastro-intestinal tract and other
peripheral organs that eventually produce the satiety feeling in the brain upon feeding.
Methods: A multilayer feed-forward neural network was trained with sets of
experimental data relating concentration-time courses of plasma satiety hormones to
Visual Analog Scales (VAS) scores. The network successfully predicted VAS responses
from sets of satiety hormone data obtained in experiments using different food
compositions.
Results: The correlation coefficients for the predicted VAS responses for test sets
having i) a full set of three satiety hormones, ii) a set of only two satiety hormones, and
iii) a set of only one satiety hormone were 0.96, 0.96, and 0.89, respectively. The
predicted VAS responses discriminated the satiety effects of high satiating food types
from less satiating food types both in orally fed and ileal infused forms.
Conclusions: From this application of artificial neural networks, one may conclude
that neural network models are very suitable to describe situations where behavior is
complex and incompletely understood. However, training data sets that fit the
experimental conditions need to be available.
Keywords: Satiety, Visual analog scales (VAS), Modeling
Background
Decades of studies indicate that hunger and feeding cycles involve complex hormonal and
neuronal signal interactions, including e.g., hormone releases from the gastro-intestinal
tract and neuro-endocrine signals from peripheral organs like liver, pancreas, and stom-
ach to the brain [1]. Satiety is that satisfactory feeling of fullness attained as a result of
feeding [2]. The hormones released by the gastro-intestinal tract associated to satiety,
have also been subject of numerous obesity-and diabetes-related studies [3, 4]. Although
there are many hormones relating to hunger and satiety [5], the three key hormones
appear to be the glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), and peptide YY
(PYY) [6, 7]. GLP-1 is mainly secreted by the distal part of the small intestine, the ileum
[8], whereas CCK is secreted in the duodenum and PYY in the ileum [9, 10].
The amount of satiety hormones released from the gastro-intestinal tract, and thus
their satiating effects, are related to the composition and the amount of nutrient ingested
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[11, 12]. High protein diets produce higher satiating effects than low protein diets [13].
Some evidence suggests that dietary protein is more satiating than carbohydrate or fat
[14, 15]. Also, there are location specific satiety effects of nutrients along the gastro-
intestinal tract. Particularly, activating the distal part of the gut, the ileum, produced the
maximal satiety effects in terms of reduction in hunger and food intake [16]. This neuro-
endocrine negative feed back signaling scheme that results in producing satiating affects
is known as the ileal brake [17, 18].
One of the most commonly used indices for sensations for appetite is the Visual Analog
Scales (VAS) [19]. The VAS scores evaluate desire to eat, hunger, fullness and satiety.
These VAS scores on a 100 pt scale are marked on a 100 mm long paper with 0 and
100 corresponding to a low and a high appetite respectively. For example, 0 (low) score
for hunger meant that the subject is not at all hungry, while a 100 (high) meant that the
subject is extremely hungry [20]. The reproducibility, power and validity of this index
have been well established [21, 22].
Modeling a complex physiological system that predicts the VAS response curves relat-
ing to appetite sensation in a deterministic or a mechanistic form is a complicated task.
However, machine learning methods like an artificial neural network (ANN) can be
applied to learn the patterns of VAS response curves given satiety signal measurements
such as time courses of satiety hormone concentrations. Neural network modeling is
one of the most promising modeling techniques with many applications in biology and
medicine [23–28].
ANNs are simple abstractions of biological neurons realized on a computer as a
software program. Similar to a biological neural network, ANN consists of computer pro-
grammed processing units (nodes) that are interconnected in a way that signals from the
input travel through the interconnected nodes to the output. Once an ANN is realized on
a computer, it can be trained with appropriate data to create useful input-output transfer
functions, and thus various applications [29].
Some of the compelling reasons to use ANNs for modeling complex behavior as VAS
response curves relating to appetite sensation are that they do not require mechanistic
details of the underlying physiology, are workable with available data, and allow for imme-
diate predictions. To our knowledge, ANN’s have not yet been applied to predict hunger
and satiety related VAS scores in humans with an exception to a statistical model that
quantitatively estimate the duration of human satiety response time [30]. Although this
statistical model is capable to estimate the duration of VAS response score for hunger
to return to baseline pre-prandial levels after a meal consumption, it may not be able
to reflect the observed hunger response profile due to the restrictions imposed by the
parameters of the underlying distribution. In contrast, the ANN’s have the freedom to
choose parameter values that closely approximate the VAS response curves at every
observed time point.
The objectives of the present paper are to i) build a neural network model that learns
VAS response patterns for desire to eat, hunger, fullness, and satiety from GLP-1, CCK
and PYY satiety hormone measurements, and ii) use this trained neural network model
to predict VAS response patterns for desire to eat, hunger, fullness, and satiety for a given
set of GLP-1, CCK and PYY satiety hormone measurements. The results of such a pre-
diction will be considered acceptable if i) the correlation coefficients of the prediction
and the measured VAS responses are above 0.85, and ii) the predicted VAS responses
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can discriminate the satiety effects of varying food composition types fed either orally or
gastrointestinally infused.
Methods
Multilayer feed-forward neural network
For the purpose of predicting hunger and appetite related VAS responses, a multilayer
feed-forward neural network was built using the MATLAB®, Neural Toolbox™, R2013b
[31]. The toolbox also implements cross validation procedures, and hence is robust in
construction and not prone towards over-fitting. One of the reasons to choose a multi-
layer feed-forward neural network is for its comprehensive foundation and is one of the
widely used models in many practical applications [32]. In addition to this, the perfor-
mance of a multilayer neural network degrades gracefully in the presence of increasing
amounts of noise. One known disadvantage however is its lengthier training time [33].
A multilayer feed-forward network consists of an input layer of nodes an output layer of
nodes, and one or more hidden layers (see Fig. 1). The hidden layers are placed between
the input and the output layer. Each layer consists of one or more processing nodes. The
output of the node from one layer are connected to one or more nodes of the next layer.
Each node implements a weighted (w) sum of its inputs (U) and a bias (b) which is then
non-linearly transfered to one or more nodes of the next layer. Here, U and w are vec-
tors i.e contain multiple components. Thus for the given example in Fig. 1, a weighted
and biased input (U ∗ w1 + b1) is non-linearly transfered with a log-sigmoid function
(H = logsig(U ∗ w1 + b1)), also known as the activation function, by the hidden layer
as an input for the next layer which again is weighted, and biased and non-linearly trans-
fered to the output (Y = logsig(H∗w2+b2)). One of the reasons to choose a log-sigmoid
function is because the return values of this function is bounded and thus the magnitude
of the parameters do not grow extremely large.
Before using the network for predictive or classification purposes, the multilayer feed-
forward network (or any ANN) needs to be trained. The training is achieved by feeding
the network with sets of input-output data called the training set. The objective of training
is to estimate the weights and bias values at every node of the network such that the
trained network satisfactorily relates every input-output data from the training set. Such
Fig. 1 A multilayer feed-forward neural network. A multilayer feed-forward neural network consisting of an
input layer, an output layer, and a hidden layer. A weighted and biased input is non-linearly transferred with a
log-sigmoid function by the hidden layer as an input for the next layer which again is weighted, and biased
and non-linearly transferred to the output. Input U, weights w1 and w2, and output Y are multicomponent
vectors, while biases b1 and b2 are scalar
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a trained multilayer feed-forward neural network is capable to compute a unique output
for wide range of inputs.
The input-output training set of the multilayer feed-forward neural network contained
satiety hormone: GLP-1, CCK, PYY time resolved measurements as inputs and the time
resolved VAS scores for hunger, fullness, desire to eat, and satiety as outputs, taken from a
number of experimental studies. To capture the interaction among the three independent
time resolved satiety hormone measurements in determining the four VAS responses,
both in temporal (t) and spectral (ω) domain, the inputs were modified before training
the network. In the spectral domain, the power spectral density estimates, as a function
of frequency (ω), were calculated via the Thomson multitaper method as described in
Du et al. [34]. Thus effectively, the inputs (U) and the outputs (Y), both vectors, used
to train the multilayer feed-forward neural network model in predicting the hunger and
appetite related VAS response from satiety hormones were as shown in Eq. 1.
U = [ I(t),M(t), I(ω),M(ω)]
Y = [Vd(t),Vh(t),Vf (t),Vs(t)] (1)
where I(t), M(t) are the satiety hormone measurements and their mixed effects (see Eq. 2)
in the temporal domain and I(ω), M(ω) are the power spectral density estimates of the
satiety hormone measurements and their mixed effects (see Eq. 3) in the spectral domain.
Similarly,Vd(t),Vh(t),Vf (t),Vs(t), are the VAS response for desire to eat, hunger, fullness,
and satiety measurements in the temporal domain.
I(t) = [G(t),C(t),P(t)]
M(t) = [G(t) ∗ C(t),G(t) ∗ P(t),C(t) ∗ P(t),G(t) ∗ C(t) ∗ P(t)] (2)
I(ω) = [G(ω),C(ω),P(ω)]
M(ω) = [G(ω) ∗ C(ω),G(ω) ∗ P(ω),C(ω) ∗ P(ω),G(ω) ∗ C(ω) ∗ P(ω)] (3)
where G, C, and P are the satiety hormone GLP1, CCK, and PYY measurements
respectively.
A multilayer feed-forward neural network model, with an input, an output, and 2 hid-
den layers trained, with sufficient amount of input-output datasets will instantly predict
the VAS response for desire to eat, hunger, fullness, and satiety for an arbitrary set of
GLP-1, CKK, and PYY values measured in time. However, in practice two problems can
arise, i) not for all of the three satiety hormones, data are available ii) hormones are not
measured in the same sampling scheme as in the training set. Since these two problems
essentially amount to a missing data problem they are addressed as follows,
In the case of missing hormone data an optional multilayer feed-forward neural net-
work with an input, an output, and 2 hidden layers was implemented and appropriately
trained to predict the missing hormones set from the data set of measured satiety hor-
mones. The input and output of such a neural network is shown in Eq. 4. When provided
with one or more sets of satiety hormones, where each set contained all satiety hormones,
GLP1, CCK, and PYY from the same experimental study, the inputs and the outputs of
the neural network were iteratively trained with one satiety hormone from each set at the
input and all the three hormones from the same set at the output. Hence the number of
training sessions for each set were three. Now given an arbitrary satiety hormone, either
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GLP1, or CCK, or PYY, the trained network predicted the rest (in practice all the three
satiety hormones).
U = [X(t)]
Y = [G(t),C(t),P(t)] (4)
where X(t) is any of the satiety hormone GLP1, or CCK, or PYY measurements in the
temporal domain, and G(t), C(t), and P(t) are the satiety hormone GLP1, CCK, and PYY
measurements in the temporal domain respectively.
Similarly, in the case of filling in additional satiety hormone data outside the sampling
interval, a dynamic neural network implementing an Nonlinear Autoregressive Neural
Network (NARX) [31], capable to predict the next time series data from its previous time
series inputs and outputs, was included. The input and output of such a neural network
is shown in Eq. 5. This neural network when provided with a shorter time sequence of a
satiety hormone data, predicted the rest of the sequence until a pre-specified length.
U = [X(t − L)]
Y = [X(t)] (5)
where X(t) is any of the satiety hormone GLP1, or CCK, or PYY measurements in the
temporal domain, and L is the time lag.
Description of datasets: Ileal infusion
Datasets for modeling included data from thirteen volunteers that were included in an
experimental study performed by the Top Institute Food and Nutrition (TIFN) to assess
the effect of different macro-nutrients on ileal brake activation1 [35]. Briefly, thirty min-
utes after breakfast, a solution containing either saline (placebo) or safflower oil ((SO),
51.7 kcal) or Sucrose-low (17.2 kcal) or Sucrose-high (51.7 kcal) or Casein-low (17.2 kcal)
or Casein-high (51.7 kcal) was infused into the ileum using a catheter. From the volun-
teers, blood samples and VAS for desire to eat, hunger, fullness and satiety, were collected
at various time points after breakfast. From each blood sample, the plasma concentrations
of satiety hormones GLP1, CCK, and PYY were measured.
The training set and the test set chosen from this study for neural net training and
testing purposes are shown in Table 1. The training set, Dataset A, had 2 subsets of data,
while the test set, Dataset B, had three subsets of data. Each subset contained satiety
hormone and VAS measurements from 13 volunteers. In the training set, measurements
for all satiety hormones required for the neural net training were available, while in the
test set, data for the satiety hormone, CCK were missing.
Description of datasets: Oral intake and gastric infusion
As a second training set, Data set C, (Table 2) generated from a study performed by the
TIFN at the Wageningen University & Research centre [36] was chosen. The intention
of the study was to measure the effect of gastric processing of liquid fat formulations on
the timing of the release of the fat to the small intestine and the effect of this on the time
evolution of intestinal hormone release into blood circulation and how this relates to the
evolution of feelings of hunger and satiety.
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Table 1 Description of datasets: Ileal infusion, training set: Dataset A, and the test set: Dataset B,
employing ileal macronutrient perfusion [35]
Data Source Data Name G C P H S F D Sub Ts Te Ml/If NPS
Dataset A Placebo ✓ ✓ ✓ ✓ ✓ ✓ ✓ 13 –15 240 0, 30–120 10
Safflower ✓ ✓ ✓ ✓ ✓ ✓ ✓ 13 –15 240 0, 30–121 10
Dataset B Casein-high ✓ ✓ ✓ ✓ ✓ ✓ ✓ 13 –15 240 0, 30–122 10
Casein-low ✓ ✗ ✓ ✓ ✓ ✓ ✓ 13 –15 240 0, 30–123 10
Sucrose-high ✓ ✗ ✓ ✓ ✓ ✓ ✓ 13 –15 240 0, 30–123 10
The letters or abbreviation in the headers are as follows: DataName = the perfusion macro-nutrient type; G = GLP-1 (pmol/l); C =
CCK (pmol/l); P = PYY (pg/ml); H = VAS for Hunger; S = VAS for Satiety; F = VAS for Fullness; D = VAS for Desire to eat; Sub =
Number of subjects; Ts = Tstart (min); Te = Tend (min); Ml/If = time point/range for Meal/Infusion; NPS = Number of Plasma
Samples. A check mark (✓) indicates that the corresponding satiety hormone measurements and/or VAS scores were available,
while a cross mark (✗) indicates non-availability of the measurements
To this end, 15 volunteers received 500 ml dosages of 8 % sunflower oil, 0.4 % Tween
80 and 91.6 % water, corresponding to an energy content of 360 kcal. These dosages were
given orally (homogenised oral(ho)), by gastric infusion (homogenised stomach(hs)) or in
the form of a gastric infusion of water followed by the oil phase (unhomogenised stom-
ach(uhs)). Blood samples were collected at various time points to measure GLP-1, CCK,
and PYY concentrations [36].
As a second test set, Data set D, (Table 2) generated in a study performed at Aarhus
University Hospital, Aarhus, Denmark, on 15 Caucasian subjects having the metabolic
syndrome to investigate the impact of arabinoxylan, β-glucan and whole grain rye
compared with refined wheat on glycaemia and satiety2 [37] were chosen. The study
employed meals of refined wheat breads supplemented with concentrates of arabinoxy-
lan (data1(d1)), or concentrates of β-glucan (data2(d2)), whole grain rye bread (data3(d3))
and refined wheat bread (data4(d4)). After the meal intake, blood samples were drawn
from volunteers at various time points in addition to assessment of appetite sensation
(VAS for desire to eat, hunger, fullness, and satiety). From each blood sample, the plasma
concentration of the satiety hormone GLP-1 was measured.
Results and discussion
In the following sections the results of applying the respective trained neural networks
in VAS response prediction for the various test sets shown in Tables 1 and 2 will be
discussed.
Table 2 Description of datasets: Oral intake and gastric infusion, Dataset C, and the test set: Dataset
D. Dataset C used meals and gastric infusions, whereas dataset D only used meals
Data Source Data Name G C P H S F D Sub Ts Te Ml/If NPS
Dataset C ho ✓ ✓ ✓ ✓ ✓ ✓ ✓ 15 –10 180 30 9
hs ✓ ✓ ✓ ✓ ✓ ✓ ✓ 15 –10 180 30 9
uhs ✓ ✓ ✓ ✓ ✓ ✓ ✓ 15 –10 180 30 9
Dataset D d3 ✓ ✗ ✗ ✓ ✓ ✓ ✓ 15 0 270 0 10
d4 ✓ ✗ ✗ ✓ ✓ ✓ ✓ 15 0 270 0 10
The letters or abbreviation in the headers are as follows: DataName = macro-nutrient type or intake form; G = GLP-1 (pmol/l); C =
CCK (pmol/l); P = PYY (pg/ml); H = VAS for Hunger; S = VAS for Satiety; F = VAS for Fullness; D = VAS for Desire to eat; Sub =
Number of subjects; Ts = Tstart (min); Te = Tend (min); Ml/If = time point/range for Meal/Infusion; NPS = Number of Plasma
Samples. A check mark (✓) indicates that the corresponding satiety hormone measurements and/or VAS scores were available,
while a cross mark (✗) indicates non-availability of the measurements
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Predicting VAS profiles for test sets with ileal infusion (complete satiety hormone data)
All satiety hormone measurements were available for Dataset B with the DataName:
Casein-high. The VAS profiles for hunger, fullness, desire to eat, and satiety predicted
from measured GLP-1, PYY, and CCK are shown in Fig. 2. The respective correla-
tion coefficients for Desire to eat, Hunger, Fullness, Satiety were 0.96, 0.95, 0.95, and
0.98.
Predicting VAS profiles for test sets with ileal infusion (incomplete satiety hormone data)
For the test set Dataset B with the DataName: Casein-low and Sucrose-high, satiety hor-
mone measurements were available for GLP-1 and PYY but not for CCK. Therefore, CCK
was predicted from GLP-1 and PYY using a separately trained (i.e. on dataset A) ANN.
The ANN-predicted CCK responses averaged over 13 volunteers are shown in Fig. 3.
Similarly, the VAS profiles for hunger, fullness, desire to eat, and satiety predicted from
measured GLP-1, PYY, and predicted CCK are shown in Fig. 4. The correlation coefficient
values were [Casein-low: 0.99; Sucrose-high: 0.96], [Casein-low: 0.98; Sucrose-high: 0.94],
[Casein-low: 0.97; Sucrose-high: 0.96], and [Casein-low: 0.97; Sucrose-high: 0.97] for the
Desire to eat, Hunger, Fullness, and satiety VAS responses, respectively. The predicted
VAS response profiles showed higher satiety effects for Sucrose-high infusion compared
to Casein-low infusion and that was expected.
In order to test which of the satiety hormones were most relevant in predicting the
VAS profile, a test set, Casein-high, with all satiety hormones measured was chosen from
Fig. 2 Measured and predicted VAS profile. Measured and predicted VAS profile (clockwise from top-left):
Desire to eat, Hunger, Fullness, Satiety and for test set Dataset B: Casein-high infusion averaged over 13
volunteers. The respective correlation coefficients for Desire to eat, Hunger, Fullness, Satiety are 0.96, 0.95,
0.95, and 0.98
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Fig. 3 Predicted CCK response. Predicted CCK response averaged over 13 volunteers for Dataset B:
Casein-low and Sucrose-high infusions. The dots indicate the predicted CCK concentrations for individual
volunteers at various time points. The dots are connected and smoothened to represent the respective CCK
concentration over time
Dataset B and its VAS responses were predicted. This was followed by iteratively remov-
ing one or two satiety hormones and creating a new test set. The VAS responses were then
predicted for the newly created test set. Table 3 shows the results for the various combi-
nations of hormone input data. As can be seen from the correlation coefficient averages,
the test data with GLP-1 alone is as good as the rest.
Fig. 4 Measured and predicted VAS profile. Measured and predicted VAS profile (clockwise from top-left):
Desire to eat, Hunger, Fullness, Satiety for test set Dataset B: Casein-low and Sucrose-high infusions averaged
over 13 volunteers. The respective correlation coefficients for Desire to eat, Hunger, Fullness, Satiety are [0.99;
0.96], [0.98; 0.94], [0.97; 0.96], and [0.97; 0.97]
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Table 3 R-Correlation coefficient for predicted vs. measured VAS responses for different
combinations of hormone input data as indicated (✓ = present, ✗ = absent) for casein-high infusion
in Dataset B. VAS scores: D = Desire to eat; H = Hunger; F = Fullness; S = Satiety
Test data GLP1 CCK PYY
Correlation Coefficient (R)
D H F S Average
a. ✓ ✗ ✗ 0.963 0.957 0.959 0.991 0.966
b. ✓ ✓ ✓ 0.963 0.957 0.956 0.989 0.965
c. ✓ ✓ ✗ 0.961 0.951 0.951 0.986 0.961
d. ✓ ✗ ✓ 0.957 0.944 0.972 0.964 0.959
e. ✗ ✓ ✓ 0.952 0.935 0.947 0.982 0.953
f. ✗ ✓ ✗ 0.955 0.940 0.942 0.980 0.953
g. ✗ ✗ ✓ 0.937 0.912 0.964 0.974 0.945
Predicting VAS profiles for test sets with oral intake and gastric infusion
The training set Dataset C (Table 2) contained responses for all three satiety hormones
and VAS response measurements until 180 min. For the test set Dataset D, GLP-1 was the
only satiety hormone for which measurements were present, while the GLP-1 response
and the VAS responses were measured during a much longer period i.e. until 270 min.
Since the training set did not adequately cover the time range of the test set, the miss-
ing information was filled with the the autoregressive neural network as described in
Methods: Multilayer feed-forward Neural Network.
The CCK and PYY responses predicted using an ANN trained on training set C, and
using only GLP-1 responses as input are shown in Fig. 5. The predicted VAS score for
desire to eat, hunger, fullness and satiety then predicted from measured GLP1 and pre-
dicted CCK, and PYY are shown in Fig. 6. The correlation coefficient values were [d3: 0.90;
d4: 0.87], [d3: 0.88; d4: 0.85], [d3: 0.90; d4: 0.91], and [d3: 0.93; d4: 0.93] for the Desire to
eat, Hunger, Fullness, and satiety VAS responses, respectively. The apexes (negative and
positive peaks) of the predicted and the measured VAS responses did not match because
the number of measurements available in the test set around the neighborhood of the
apex were not sufficient enough to estimate the amplitude of the predicted VAS score in
right proportion.
Conclusion
Artificial neural networks (ANNs) provides an appropriate platform for modeling the
complex input-output relationship between satiety hormones (GLP-1, PYY, and CCK) and
Fig. 5 Predicted CCK and PYY responses. Predicted CCK (left) and PYY (right) responses averaged over 15
volunteers for Dataset D: d3, and d4
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Fig. 6 Measured and predicted VAS profiles. Measured and predicted VAS profiles (clockwise from top-left):
Desire to eat, Hunger, Fullness and Satiety for Dataset D: d3, and d4 averaged over 15 volunteers. The
prediction was based only on the GLP-1 data, from which CCK and PYY responses were predicted using
separate ANNs. The respective correlation coefficients for d3, and d4 are [0.90; 0.87], [0.88; 0.85], [0.90; 0.91],
and [0.93; 0.93]
satiety feelings in the brain as quantified by VAS scores (desire to eat, hunger, fullness and
satiety). Application of ANN to predict satiety behavior produced satisfactory results. The
obtained results upon systematically varying the combination of satiety hormone input
data suggest that the presence of the satiety hormone GLP-1 is pivotal in determining
the quality of the VAS response prediction. It also appeared that for achieving high qual-
ity VAS response prediction, the training sets should minimally contain measurements at
time points when satiety hormones are expected to peak or valley in the test sets.
Endnotes
1 volunteers signed a written informed consent prior to participation, the study was
conducted according to the principles of the Declaration of Helsinki, the Medical Ethics
Committee of the University Hospital Maastricht and Maastricht University (METC
azM/UM) approved the study.
2 All subjects gave their written informed consent to participate in the study and the
Central Denmark Region Committees on Health Research Ethics approved the study
according to the Helsinki Declaration. The study was registered at Clinical trials. Gov ID:
NCT01316354.
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